Erkurt M.A.Aydogdu I.Kuku I.Kaya E.Mizrak B.Basaran Y.2024-08-042024-08-0420091757-1626https://doi.org/10.4076/1757-1626-2-8183https://hdl.handle.net/11616/91799Introduction: Three histological variants (hyaline vascular, plasma cell, and mixed) and two clinical types (localized and multicentric) of Castleman's disease have been described. The risk of progression to lymphoma is higher in multicentric Castleman's disease and is associated with poorer outcomes and higher mortality rate. Multicentric Castleman's disease often requires systemic therapy. Complete resection of the involved node in localized Castleman's disease is curative, with no reported recurrences. Case presentation: We report a case of a 66-year-old female with systemic symptoms and bilateral cervical lymph nodes which were initially diagnosed as the hyaline vascular variant of Castleman's disease and two years later after the initial diagnosis she was confirmed to B cell lymphoma. Following the treatment with radiation therapy to the cervical area and combination chemotherapy complete response was achieved. Conclusion: Although it has rarely been reported, the malignant potential of the Castleman's disease must be kept in mind. © 2009 Erkurt et al; licensee Cases Network Ltd.eninfo:eu-repo/semantics/openAccessCD19 antigenCD20 antigenCD22 antigenCD3 antigenCD30 antigenCD4 antigenCD45 antigenCD5 antigenCD8 antigenCD99 antigencommon acute lymphoblastic leukemia antigencyclophosphamidedoxorubicinprednisonevincristineabdominal radiographyagedangiofollicular lymph node hyperplasiaarticleB cell lymphomacancer combination chemotherapycancer radiotherapycase reportcase studycervical lymph nodedyspneafemalefollow uphistopathologyhumanlymph node biopsylymph node hyperplasialymphadenopathypainphysical examinationtreatment responseArticle2610.4076/1757-1626-2-81832-s2.0-77953391199N/A